Chronic Myeloid Leukemia Accelerated Phase
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia Accelerated Phase.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating ponatinib in combination with chemotherapy for acute lymphoblastic leukemia and BCR-ABL1-positive leukemias, includ…
-
CLINICAL_TRIALS other · 2025-04-29Clinical Trial Update: MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing [NA]
Clinical trial update from the Medical College of Wisconsin describes a study using targeted antithymocyte globulin dosing to deplete alpha/…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML [Phase 2]
Phase 2 trial evaluating a decitabine and HQP1351-based chemotherapy regimen for advanced chronic myeloid leukemia with blast crisis/transfo…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Chronic Myelod Leukemia Registry at Asan Medical Center
The Chronic Myeloid Leukemia Registry at Asan Medical Center has been terminated. The registry covers chronic myeloid leukemia in chronic ph…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the use of nilotinib and imatinib after donor stem cell transplant in patients with acute ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating the combination of Triapine (3-AP) and fludarabine in various myeloproliferative disorders and advanced phases of c…
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating STI571 (imatinib) in patients with accelerated-phase chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]
This clinical trial update summarizes a Phase 1 study of Imatinib Mesylate in patients with advanced cancer and liver dysfunction, which has…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 study of BMS-354825 (dasatinib) in patients with chronic myeloid leukemia in chronic, accelerated, or blast phases and Philadelphi…